IDEAYA Biosciences, Inc. (IDYA) Stock Price, Latest News, Company Profile & Institutional Holding

#ThinkSabio Latest News

IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma